Cite
Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL
MLA
Roberts, Kathryn G., et al. Oncogenic Role and Therapeutic Targeting of ABL-Class and JAK-STAT Activating Kinase Alterations in Ph-like ALL. Sept. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....f667d8e6f26d6d3cb3c22e6484d171c6&authtype=sso&custid=ns315887.
APA
Roberts, K. G., Yang, Y.-L., Payne-Turner, D., Files, J. K., Dickerson, K., Gu, Z., Janke, L. J., Mullighan, C. G., Wenwei Lin, Chen, T., Taunton, J., Loh, M. L., & Hunger, S. P. (2017). Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL.
Chicago
Roberts, Kathryn G., Yung-Li Yang, Debbie Payne-Turner, Jacob K. Files, Kirsten Dickerson, Zhaohui Gu, Laura J. Janke, et al. 2017. “Oncogenic Role and Therapeutic Targeting of ABL-Class and JAK-STAT Activating Kinase Alterations in Ph-like ALL,” September. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....f667d8e6f26d6d3cb3c22e6484d171c6&authtype=sso&custid=ns315887.